Special cases

My LDL is at goal on a statin but my ApoB is high. What now?

By GyroscopeUpdated November 15, 20264 sources

It’s common, and it’s the exact case ApoB testing is for. Across 11 trials, LDL-lowering medicine cut LDL by 42% on average but ApoB by only 33%, so LDL often reaches its goal first. The 2026 US guideline says measuring ApoB once your LDL goal is met is reasonable, to decide whether to do more. Take both numbers to the person who prescribes your medicine.

Why statins lower LDL more than ApoB

A statin works by helping your liver pull particles out of your blood. It’s better at clearing the big, cholesterol-rich LDL particles than the small, cholesterol-poor ones, the National Lipid Association says. That’s why the cholesterol total (LDL) falls faster than the particle count (ApoB), and what’s left is more particles carrying less each.

It’s like a tow truck that clears the fully loaded trucks off a highway first. The cargo total drops fast, and the road still has plenty of half-empty trucks on it.

What it means for risk

In Copenhagen, researchers followed 13,015 people on statins for a median of 8 years. Compared with people whose ApoB and LDL were both below the middle, people with ApoB above the middle and LDL below had 1.49 times the heart attacks and 1.21 times the deaths from any cause. A high LDL with a low ApoB wasn’t tied to more of either.

The guideline gives this case its own recommendation, rated class 2a. In adults on cholesterol medicine, “particularly those with ASCVD, CKM syndrome, type 2 diabetes, and/or elevated TG”, measuring ApoB “is reasonable to guide decisions regarding further therapeutic intensification” once LDL and non-HDL goals are met.

What “doing more” can mean

That decision is your prescriber’s. The guideline says ApoB can help decide on nonstatin medicines, and names ezetimibe, bempedoic acid, PCSK9 antibodies and inclisiran. In the trials the NLA summarizes, adding ezetimibe to a statin lowered ApoB a further 15%, and adding a PCSK9 antibody lowered it more than 40%. For people with heart disease and severe high cholesterol, the guideline says aiming for an ApoB under 55 may be reasonable once the LDL and non-HDL goals are met.

Questions to bring

• My ApoB is this, and my LDL is that. Is my ApoB at the goal for my risk?
• Should we check my triglycerides, blood sugar and thyroid as causes?
• Would adding another medicine make sense for me, and what would we expect it to do?
• When should I retest, and at the same lab?

If a side effect is bothering you, tell your prescriber before you change anything. Food changes still add to a medicine, if you want to and can, and How do I lower ApoB naturally? has the plan.